Policy | November 11, 2025
Trump clinches historic deal as Lilly, Novo slash U.S. weight-loss drug prices
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
Organic capex during the quarter amounted to Rs. 491.1 crore, supporting ongoing business expansion initiatives
Relmada expects to initiate its Phase 3 program in the first half of 2026
The upcoming facility marks a strategic milestone in SOUKYA’s mission to make evidence-based holistic healthcare
The FDA setback highlights ongoing tensions between patient needs, regulatory processes, and the use of real-world evidence in evaluating treatments for rare diseases
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
Syngene International has reported total income of Rs. 926 crore during the period ended September 30, 2025
Sales from Novo’s GLP-1 portfolio—including Wegovy for obesity and Ozempic for type 2 diabetes reached $5.6 billion
This latest commitment brings the British pharmaceutical company’s total investment at the site to $886 million
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible
Subscribe To Our Newsletter & Stay Updated
